Credit: Shutterstock photoBecton Dickinson ( BDX ) saw a positive improvement to its Relative Strength ( RS ) Rating on Friday, rising from 67 to 80.
[ibd-display-video id=2360792 width=50 float=left autostart=true] IBD's unique RS Rating measures technical performance by using a 1 (worst) to 99 (best) score that identifies how a stock's price performance over the last 52 weeks matches up against the rest of the market.
Decades of market research shows that the stocks that go on to make the biggest gains typically have an RS Rating of at least 80 as they launch their biggest climbs.
Looking For The Best Stocks To Buy And Watch? Start Here
Becton Dickinson has moved more than 5% past a 206.73 entry in a first-stage flat base , meaning it's now out of a proper buy range. Look for the stock to create a new buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.
Earnings grew 13% last quarter, up from 5% in the prior report. Revenue also increased, from -5% to -2%.
Becton Dickinson earns the No. 1 rank among its peers in the Medical-Supplies industry group. West Pharmaceutical Services ( WST ) and V W R ( VWR ) are also among the group's highest-rated stocks.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.